title: Altered hippocampal kainate-receptor mRNA levels in temporal lobe epilepsy patients.
abstract: This study determined whether hippocampal kainate (KA) receptor mRNA levels were increased or decreased in temporal lobe epilepsy patients compared with nonseizure autopsies. Hippocampal sclerosis (HS; n = 17), nonsclerosis (non-HS; n = 11), and autopsy hippocampi (n = 9) were studied for KA1-2 and GluR5-7 mRNA levels using semiquantitative in situ hybridization techniques, along with neuron densities. Compared with autopsy hippocampi, HS and non-HS cases showed decreased GluR5 and GluR6 hybridization densities per CA2 and/or CA3 pyramid. Furthermore, HS patients demonstrated increased KA2 and GluR5 hybridization densities per granule cell compared with autopsy hippocampi. These findings indicate that chronic temporal lobe seizures were associated with differential changes in hippocampal KA1-2 and GluR5-7 hybridization densities that vary by subfield and pathology group. In temporal lobe epilepsy patients, these results support the hypothesis that pyramidal cell GluR5 and GluR6 mRNA levels are decreased as a consequence of seizures, and in HS patients granule cell KA2 and GluR5 mRNA levels are increased in association with aberrant fascia dentata mossy fiber sprouting and/or hippocampal neuronal loss.
authors.affiliation: Division of Neurosurgery, University of California, Los Angeles 90095, USA.
authors.forename: G W
authors.initials: GW
authors.lastname: Mathern
authors.forename: J K
authors.initials: JK
authors.lastname: Pretorius
authors.forename: H I
authors.initials: HI
authors.lastname: Kornblum
authors.forename: D
authors.initials: D
authors.lastname: Mendoza
authors.forename: A
authors.initials: A
authors.lastname: Lozada
authors.forename: J P
authors.initials: JP
authors.lastname: Leite
authors.forename: L
authors.initials: L
authors.lastname: Chimelli
authors.forename: D E
authors.initials: DE
authors.lastname: Born
authors.forename: I
authors.initials: I
authors.lastname: Fried
authors.forename: A C
authors.initials: AC
authors.lastname: Sakamoto
authors.forename: J A
authors.initials: JA
authors.lastname: Assirati
authors.forename: W J
authors.initials: WJ
authors.lastname: Peacock
authors.forename: G A
authors.initials: GA
authors.lastname: Ojemann
authors.forename: P D
authors.initials: PD
authors.lastname: Adelson
mesh_terms: D000328:Adult; D000818:Animals; D001344:Autopsy; D017029:Epilepsy, Complex Partial / Q000378:metabolism; D004833:Epilepsy, Temporal Lobe / Q000378:metabolism*; D018698:Glutamic Acid / Q000378:metabolism; D006624:Hippocampus / Q000166:cytology*; D006801:Humans; D017403:In Situ Hybridization; D007395:Interneurons / Q000737:chemistry / Q000378:metabolism*; D008297:Male; D008875:Middle Aged; D012333:RNA, Messenger / Q000032:analysis; D051381:Rats; D017207:Rats, Sprague-Dawley; D018092:Kainic Acid Receptors / Q000235:genetics* / Q000378:metabolism; D013569:Synapses / Q000737:chemistry / Q000378:metabolism; D009435:Synaptic Transmission / Q000502:physiology; D000097806:GluK2 Kainate Receptor; D000097808:GluK3 Kainate Receptor
chemical_list: D018698:Glutamic Acid; D012333:RNA, Messenger; D018092:Kainic Acid Receptors; D000097806:GluK2 Kainate Receptor; D000097808:GluK3 Kainate Receptor